Trexquant Investment LP grew its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 105.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 170,486 shares of the healthcare company's stock after purchasing an additional 87,305 shares during the period. Trexquant Investment LP owned approximately 0.25% of InMode worth $2,847,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Quarry LP boosted its holdings in InMode by 154.3% during the third quarter. Quarry LP now owns 3,781 shares of the healthcare company's stock worth $64,000 after buying an additional 2,294 shares in the last quarter. SBI Securities Co. Ltd. acquired a new stake in shares of InMode during the 4th quarter valued at approximately $87,000. Farther Finance Advisors LLC boosted its stake in shares of InMode by 26.2% during the 4th quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company's stock worth $93,000 after acquiring an additional 1,154 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of InMode by 6.2% in the 3rd quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company's stock worth $169,000 after acquiring an additional 579 shares during the period. Finally, WINTON GROUP Ltd purchased a new position in InMode in the 4th quarter valued at approximately $174,000. 68.04% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have commented on INMD shares. Needham & Company LLC reiterated a "hold" rating on shares of InMode in a research report on Wednesday. Barclays lifted their price target on InMode from $26.00 to $29.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, InMode presently has an average rating of "Hold" and an average target price of $22.25.
Check Out Our Latest Stock Analysis on InMode
InMode Price Performance
InMode stock traded up $0.78 during mid-day trading on Friday, hitting $14.88. 1,862,893 shares of the company were exchanged, compared to its average volume of 1,180,383. InMode Ltd. has a 12-month low of $13.68 and a 12-month high of $19.85. The business's 50 day simple moving average is $18.01 and its two-hundred day simple moving average is $17.67. The company has a market capitalization of $1.04 billion, a P/E ratio of 6.33 and a beta of 1.96.
InMode Company Profile
(
Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
See Also
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
